Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities: 2009-2012

Historic Cash from Investing Activities for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to -$6.7 million.

  • Lexicon Pharmaceuticals' Cash from Investing Activities fell 137.32% to -$6.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$97.8 million, marking a year-over-year decrease of 239.81%. This contributed to the annual value of -$15.4 million for FY2024, which is 69.21% up from last year.
  • Lexicon Pharmaceuticals' Cash from Investing Activities amounted to -$6.7 million in Q4 2012, which was down 157.80% from $11.6 million recorded in Q3 2012.
  • Over the past 5 years, Lexicon Pharmaceuticals' Cash from Investing Activities peaked at $30.7 million during Q3 2011, and registered a low of -$145.1 million during Q4 2010.
  • Its 3-year average for Cash from Investing Activities is -$11.8 million, with a median of $6.9 million in 2010.
  • Per our database at Business Quant, Lexicon Pharmaceuticals' Cash from Investing Activities crashed by 26,578.28% in 2010 and then soared by 3,894.94% in 2011.
  • Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Cash from Investing Activities stood at $548,000 in 2009, then tumbled by 26,578.28% to -$145.1 million in 2010, then surged by 112.43% to $18.0 million in 2011, then slumped by 137.32% to -$6.7 million in 2012.
  • Its Cash from Investing Activities was -$6.7 million in Q4 2012, compared to $11.6 million in Q3 2012 and $26.9 million in Q2 2012.